A Randomized, Controlled, Prospective and Multicenter Clinical Investigation Evaluating the Safety and Performance of ABIO3419 in Treating Knee Osteoarthritis.
Latest Information Update: 07 Oct 2024
At a glance
- Drugs ABIO 3419 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Symatese
- 30 Sep 2024 New trial record